# TOLMAR, INC. hires BROWNSTEIN HYATT FARBER SCHRECK, LLP (Pharmacy)

**Score:** 45/100

| Field | Value |
|---|---|
| Client | TOLMAR, INC. |
| Client description | Pharmaceutical company |
| Client state | CO |
| Lobbying firm | BROWNSTEIN HYATT FARBER SCHRECK, LLP |
| Firm state | DC |
| Issue areas | Pharmacy |
| Specific matters disclosed | Advocacy around issues affecting the pharmaceutical industry, such as the Medicare Drug Price Negotiation Program under the Inflation Reduction Act. |
| Registered | 2026-09-21 |

## Why this score
- Specific matters disclosed.

Source: U.S. Senate and House Lobbying Disclosure Act (LDA) filings via lda.gov; Colorado Secretary of State, NYC City Clerk eLobbyist and City of Chicago Board of Ethics lobbying data (https://lda.gov/filings/public/filing/0c766752-e028-4a50-a76b-98d1d11c9a7e/print/). Last refreshed: 2026-11-03T19:42:41.566Z.
From public Lobbying Disclosure Act registrations (lda.gov) and Colorado, New York City and City of Chicago lobbying disclosures. Organization level only: we never list lobbyist, CEO or contact names, and clients whose name reads as a person are left out. Chicago amounts are lobbyist compensation reported for the quarter, summed by client. A registration reports intent to lobby; it is not evidence of wrongdoing.